Gene · 2673
Papers1,425
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,425
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic reprogramming signature predicts prognosis and immune landscape in small cell lung cancer: MOCS2 validation and implications for personalized therapy. | Front Mol Biosci | 2025 | 40452920 | PubTator, text mining | PubMed |
| The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets. | Cancer Cell | 2025 | 40446800 | PubTator, text mining | PubMed |
| A cohort of GFPT1 related congenital myasthenic syndrome in China: high frequency of c.331 c > t variant. | Orphanet J Rare Dis | 2025 | 40442802 | PubTator, text mining | PubMed |
| Glycosyltransferases: glycoengineers in human milk oligosaccharide synthesis and manufacturing. | Front Mol Biosci | 2025 | 40370521 | PubTator, text mining | PubMed |
| The status of studies on the mechanism of microcirculatory dysfunction in the process of diabetic kidney injury. | Diabetol Metab Syndr | 2025 | 40369631 | PubTator, text mining | PubMed |
| Proteomic analysis reveals potential biomarker candidates in serous ovarian tumors - a preliminary study. | Contemp Oncol (Pozn) | 2025 | 40330446 | PubTator, text mining | PubMed |
| Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth. | Sci Adv | 2025 | 40249802 | PubTator, text mining | PubMed |
| GFPT1-related congenital myasthenic syndrome misdiagnosed as myopathy: clinical and genetic insights. | Acta Neurol Belg | 2025 | 40232331 | PubTator, text mining | PubMed |
| Starvation-induced HBP metabolic reprogramming and STAM2 O-GlcNAcylation facilitate bladder cancer metastasis. | Sci Rep | 2025 | 40075080 | PubTator, text mining | PubMed |
| Influencing factors and quality traits of pigeon meat: A systematic review. | Poult Sci | 2025 | 40068574 | PubTator, text mining | PubMed |
| siRNA-Encapsulated Biomimetic Liposomes Effectively Inhibit Tumor Cells' Hexosamine Biosynthesis Pathway for Attenuating Hyaluronan Barriers to Pancreatic Cancer Chemotherapy. | ACS Nano | 2025 | 39978787 | PubTator, text mining | PubMed |
| Performance and mechanism of nano Fe-Al bimetallic oxide enhanced constructed wetlands for the treatment of Cr(VI)-contaminated wastewater. | Environ Res | 2025 | 39971118 | PubTator, text mining | PubMed |
| Buckwheat protein-derived peptide ameliorates insulin resistance by directing O-linked N-acetylglucosamine transferase to regulate the SIRT1/PGC1α pathway. | Int J Biol Macromol | 2025 | 39947565 | PubTator, text mining | PubMed |
| Comparative analysis of senescence induction by different chemotherapeutic agents in HCT116 colon cancer cells. | Biochem Biophys Res Commun | 2025 | 39946980 | PubTator, text mining | PubMed |
| Silencing of O-GlcNAc Transferase Attenuated O-GlcNAcylation and Metastatic Potentials of Melanoma Cells Through Suppression of Akt-NFκB Signaling Pathway. | Chembiochem | 2025 | 39878235 | PubTator, text mining | PubMed |
| Phenotypic variability in congenital myasthenic syndrome with GFPT1 mutation. | Acta Neurol Belg | 2025 | 39602055 | PubTator, text mining | PubMed |
| Metabolic coupling of aerobic methane oxidation and short-cut nitrification and denitrification for anaerobic effluent treatment in photo-sequencing batch biofilm reactor. | Bioresour Technol | 2025 | 39566691 | PubTator, text mining | PubMed |
| KDM4C and GFPT1: Potential Therapeutic Targets for Gastric Cancer. | Discov Med | 2024 | 39726315 | PubTator, text mining | PubMed |
| Causal Association of Adipose Tissue with Bladder Cancer and the Mediating Effects of Circulating Metabolites: A Mendelian Randomization Study. | J Cancer | 2024 | 39668829 | PubTator, text mining | PubMed |
| Bioinformatics insights into the role of GFPT1 in breast invasive carcinoma: implications for tumor prognosis, immune modulation, and therapeutic applications. | Front Genet | 2024 | 39664728 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2673/papers?page=4